Miami Cancer Institute — Miami, Florida

Miami Cancer Institute is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Miami Cancer Institute has participated in 186 clinical trials with 112 currently active.

Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.

Sponsors: Children's Oncology Group, Kartos Therapeutics, Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cancer Institute?

Miami Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cancer Institute conducted?

Miami Cancer Institute has 186 clinical trials on record, with 112 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.

Is Miami Cancer Institute accredited by Crixeo Health?

Miami Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.